Menu

Biology, Genetics & Bone Healing MCQs

Practice Set 46 of 212

This practice set contains high-yield board review questions covering key concepts in Biology, Genetics & Bone Healing. Each clinical scenario is designed to test your diagnostic and management skills relevant to this subspecialty.

Question 901

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of fracture healing, what is the maximum strain tolerated by lamellar bone before failure?

. 2%
. 10%
. 30%
. 50%
. 100%

Correct Answer & Explanation

. 2%

Explanation

According to Perren's strain theory, different tissues tolerate different amounts of strain before tearing. Granulation tissue can tolerate up to 100% strain, fibrous tissue and cartilage tolerate around 10-15% strain, while lamellar bone is rigid and can only tolerate about 2% strain before failing.

Question 902

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction during fracture healing and spinal fusion. Which of the following BMPs is also formally known as Osteogenic Protein-1 (OP-1)?

. BMP-2
. BMP-3
. BMP-4
. BMP-7
. BMP-9

Correct Answer & Explanation

. BMP-7

Explanation

BMP-7 is also known as Osteogenic Protein-1 (OP-1). It has been utilized commercially for nonunions and spinal fusions. BMP-2 is the active component in Infuse. BMP-3 actually has an inhibitory effect on bone formation.

Question 903

Topic: Biology, Genetics & Bone Healing

A 30-year-old female presents with a lytic lesion in the distal femur extending to the subchondral bone. Biopsy confirms a Giant Cell Tumor (GCT) of bone. If medical therapy with Denosumab is initiated, what is the primary target and mechanism of action of this drug?

. It binds to RANKL on the neoplastic mononuclear stromal cells, preventing activation of RANK on osteoclast precursors.
. It binds directly to RANK on the multinucleated giant cells, inducing cellular apoptosis.
. It inhibits osteoprotegerin (OPG), thereby decreasing osteoclast differentiation.
. It stimulates osteoblast proliferation by binding directly to the Wnt signaling pathway.
. It directly inhibits matrix metalloproteinases secreted by the tumor cells.

Correct Answer & Explanation

. It binds to RANKL on the neoplastic mononuclear stromal cells, preventing activation of RANK on osteoclast precursors.

Explanation

In GCT of bone, the true neoplastic cells are the mononuclear spindle cells, which overexpress RANKL. This RANKL binds to RANK on normal macrophages, recruiting them and causing them to fuse into reactive multinucleated giant cells (osteoclast-like cells) that destroy bone. Denosumab is a monoclonal antibody that binds directly to RANKL on the neoplastic mononuclear cells, preventing it from activating RANK on the osteoclast precursors.

Question 904

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs), particularly BMP-2 and BMP-7, play a pivotal role in osteoinduction during fracture healing. Which of the following intracellular signaling molecules are directly phosphorylated upon BMP binding to its cellular surface receptor?

. JAK/STAT
. Smad 1, 5, and 8
. beta-catenin
. c-Jun N-terminal kinase (JNK)
. Ras/MAPK

Correct Answer & Explanation

. Smad 1, 5, and 8

Explanation

BMPs exert their osteoinductive effects by binding to specific serine/threonine kinase receptors on the cell surface. This binding induces phosphorylation of intracellular receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These phosphorylated Smads then complex with the common-mediator Smad 4 and translocate to the nucleus to upregulate transcription of osteogenic genes like Runx2.

Question 905

Topic: Biology, Genetics & Bone Healing

A 32-year-old female is scheduled for curettage and cementation of a Giant Cell Tumor (GCT) of the distal femur. She was treated pre-operatively with denosumab. What is the primary mechanism of action of denosumab in the treatment of GCT of bone?

. Directly induces apoptosis of the neoplastic mononuclear stromal cells
. Binds to RANKL, inhibiting the recruitment and formation of osteoclast-like giant cells
. Binds directly to the RANK receptor on the surface of multinucleated giant cells
. Inhibits vascular endothelial growth factor (VEGF) preventing tumor angiogenesis
. Cross-links DNA in the rapidly dividing tumor cells

Correct Answer & Explanation

. Binds to RANKL, inhibiting the recruitment and formation of osteoclast-like giant cells

Explanation

In Giant Cell Tumor of bone, the neoplastic cells are the mononuclear stromal cells, which express high levels of RANK Ligand (RANKL). This RANKL recruits and stimulates normal host macrophages to fuse into osteoclast-like giant cells, which cause massive bone destruction. Denosumab is a monoclonal antibody that binds to RANKL, preventing it from binding to the RANK receptor on osteoclast precursors, thereby halting the formation and activity of the giant cells.

Question 906

Topic: Biology, Genetics & Bone Healing

Bone Morphogenetic Proteins (BMPs), such as BMP-2 and BMP-7, primarily promote osteoblastic differentiation by signaling through which of the following intracellular pathways?

. Wnt/beta-catenin pathway
. JAK-STAT pathway
. Smad 1/5/8 pathway
. MAP kinase pathway
. Notch signaling pathway

Correct Answer & Explanation

. Smad 1/5/8 pathway

Explanation

BMPs are members of the TGF-beta superfamily. They initiate signaling by binding to heterodimeric serine/threonine kinase receptors on the cell surface. This activates the receptor, which phosphorylates receptor-regulated Smads (specifically Smad 1, 5, and 8). These phosphorylated Smads form a complex with the common-partner Smad (Smad 4) and translocate to the nucleus to regulate the transcription of osteogenic genes (like Runx2/Cbfa1).

Question 907

Topic: Biology, Genetics & Bone Healing

The monoclonal antibody Romosozumab is utilized in the treatment of severe osteoporosis. Its primary mechanism of action in increasing bone mineral density is by binding to and inhibiting which of the following molecules?

. RANK Ligand (RANKL)
. Cathepsin K
. Sclerostin
. Osteoprotegerin (OPG)
. Parathyroid hormone receptor

Correct Answer & Explanation

. Sclerostin

Explanation

Romosozumab is a humanized monoclonal antibody that binds to and inhibits sclerostin. Sclerostin is normally produced by osteocytes and inhibits the Wnt/beta-catenin signaling pathway in osteoblasts, thus decreasing bone formation. By inhibiting sclerostin, Romosozumab has a dual effect: it significantly increases bone formation and mildly decreases bone resorption.

Question 908

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in osteoinduction during fracture healing. Which of the following intracellular signaling pathways is primarily activated by BMP receptor binding?

. JAK/STAT pathway
. Wnt/beta-catenin pathway
. SMAD 1/5/8 pathway
. Notch/Hes pathway
. Hedgehog/Gli pathway

Correct Answer & Explanation

. SMAD 1/5/8 pathway

Explanation

Bone morphogenetic proteins (BMPs) are members of the TGF-beta superfamily. When a BMP binds to its cell surface serine-threonine kinase receptors, it induces the phosphorylation of receptor-regulated SMADs, specifically SMAD 1, 5, and 8. These phosphorylated SMADs form a complex with the common-mediator SMAD 4, which then translocates into the nucleus to regulate the transcription of osteogenic genes like Runx2.

Question 909

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory, successful fracture healing depends on the deformation limits of different tissues within the fracture gap. What is the maximum interfragmentary strain threshold that permits the formation of lamellar bone (primary bone healing)?

. 2%
. 10%
. 20%
. 30%
. 100%

Correct Answer & Explanation

. 2%

Explanation

Perren's strain theory dictates that tissue can only form in a fracture gap if the strain does not exceed the elongation tolerance of that specific tissue. Lamellar bone requires an ultra-low strain environment of less than 2% to form. Cartilage can tolerate up to 10% strain (allowing secondary healing), and granulation tissue tolerates up to 100% strain.

Question 910

Topic: Biology, Genetics & Bone Healing

A 34-year-old female with a recurrent giant cell tumor of the distal radius is deemed unresectable and is started on denosumab therapy. What is the specific mechanism of action of this medication?

. Directly induces apoptosis of multinucleated giant cells
. Binds to RANKL, preventing its interaction with the RANK receptor
. Acts as a competitive antagonist at the OPG (osteoprotegerin) receptor
. Inhibits the farnesyl pyrophosphate synthase enzyme in the mevalonate pathway
. Stimulates osteoblastic differentiation by activating the Wnt/beta-catenin pathway

Correct Answer & Explanation

. Binds to RANKL, preventing its interaction with the RANK receptor

Explanation

Denosumab is a fully human monoclonal antibody that specifically binds to the Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL). By binding to RANKL, it prevents RANKL from activating the RANK receptor on the surface of osteoclasts and their precursors. In giant cell tumors (GCT), the neoplastic stromal cells express RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) that cause bone destruction. Denosumab inhibits this interaction, halting bone lysis.

Question 911

Topic: Biology, Genetics & Bone Healing

According to Perren's Strain Theory, the local mechanical environment dictates the type of tissue that forms in a fracture gap. What is the maximum interfragmentary strain that permits the formation of primary lamellar bone?

. Less than 1%
. Less than 2%
. Between 2% and 10%
. Between 10% and 30%
. Greater than 30%

Correct Answer & Explanation

. Less than 2%

Explanation

Perren's Strain Theory describes how tissue differentiation at a fracture site is governed by interfragmentary strain. Lamellar bone (primary bone healing without a cartilaginous intermediate) can only tolerate an interfragmentary strain of less than 2%. Strains between 2% and 10% permit woven bone formation. Strains between 10% and 30% lead to cartilage formation (enchondral ossification), and strains >30% result in granulation tissue, leading to a nonunion if not stabilized.

Question 912

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) play a crucial role in inducing osteoblastic differentiation of mesenchymal stem cells. Which of the following intracellular signaling molecules is directly phosphorylated following BMP binding to its cell-surface serine/threonine kinase receptor?

. Wnt
. Beta-catenin
. Smad 1/5/8
. Smad 2/3
. Mitogen-activated protein (MAP) kinase

Correct Answer & Explanation

. Smad 1/5/8

Explanation

Bone morphogenetic proteins (BMPs) belong to the TGF-beta superfamily. When BMP binds to its serine/threonine kinase receptor, it phosphorylates receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These phosphorylated Smads then form a complex with the common-partner Smad (Co-Smad), Smad 4, and translocate to the nucleus to regulate gene transcription. In contrast, TGF-beta primarily phosphorylates Smad 2 and 3.

Question 913

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic proteins (BMPs) are essential for bone healing. They initiate intracellular signaling primarily by binding to transmembrane receptors. Which of the following intracellular signaling molecules is directly phosphorylated following BMP receptor activation?

. JAK/STAT
. Smad 1/5/8
. c-Fos
. Wnt/beta-catenin
. NFATc1

Correct Answer & Explanation

. Smad 1/5/8

Explanation

BMPs belong to the TGF-beta superfamily. When they bind to their serine/threonine kinase cell surface receptors, they cause phosphorylation and activation of receptor-regulated Smads (R-Smads), specifically Smad 1, 5, and 8. These complex with Smad 4 to enter the nucleus and regulate gene transcription for osteoblast differentiation.

Question 914

Topic: Biology, Genetics & Bone Healing

According to Perren's strain theory of bone healing, what is the maximum amount of interfragmentary strain that can be tolerated for primary (osteonal) bone healing to occur without the formation of a visible callus?

. Less than 2%
. Between 2% and 10%
. Between 10% and 30%
. Between 30% and 50%
. Greater than 50%

Correct Answer & Explanation

. Less than 2%

Explanation

Perren's strain theory states that primary (direct) bone healing via osteonal cutting cones requires absolute stability. This occurs only when interfragmentary strain is less than 2%. Strains between 2% and 10% result in secondary bone healing (callus formation). Strains >10% typically lead to nonunion, as the strain exceeds the tolerance of bone and cartilage formation.

Question 915

Topic: Biology, Genetics & Bone Healing
A patient presents with recurrent fractures, anemia, and hepatosplenomegaly. Radiographs demonstrate diffuse osteosclerosis and a 'bone-within-a-bone' appearance. The primary defect in this disorder is related to the dysfunction of which of the following?
. Osteoblasts
. Osteoclasts
. Osteocytes
. Chondrocytes
. Fibroblasts

Correct Answer & Explanation

. Osteoclasts

Explanation

The clinical and radiographic presentation is classic for osteopetrosis (Albers-Schรถnberg disease). It is caused by a genetic defect resulting in impaired osteoclast function (e.g., defective carbonic anhydrase II, TCIRG1 mutation, or CLCN7 mutation), leading to a failure of normal bone resorption, acidification, and remodeling.

Question 916

Topic: Biology, Genetics & Bone Healing

Bone morphogenetic protein-2 (BMP-2) is heavily utilized in spine surgery for its potent osteoinductive properties. Through which of the following intracellular signaling pathways does BMP-2 primarily exert its osteogenic effect?

. Activation of the Wnt/beta-catenin pathway
. Phosphorylation of SMAD 1, 5, and 8
. Inhibition of RANKL expression
. Activation of the JAK/STAT signaling cascade
. Stimulation of fibroblast growth factor receptor 3 (FGFR3)

Correct Answer & Explanation

. Phosphorylation of SMAD 1, 5, and 8

Explanation

BMP-2 binds to a heterodimeric serine/threonine kinase receptor on the cell surface. This binding leads to the intracellular phosphorylation of receptor-regulated SMADs (SMAD 1, 5, and 8). These form a complex with the common-mediator SMAD 4, which then translocates to the nucleus to regulate the transcription of osteogenic genes such as Runx2.

Question 917

Topic: Biology, Genetics & Bone Healing

Denosumab is highly effective in the treatment of unresectable or metastatic Giant Cell Tumor of bone (GCTB). What is the specific molecular target of this medication?

. Vascular Endothelial Growth Factor (VEGF)
. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)
. Tumor Necrosis Factor alpha (TNF-alpha)
. Osteoprotegerin (OPG)
. Sclerostin

Correct Answer & Explanation

. Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL)

Explanation

Denosumab is a fully human monoclonal antibody that binds to and inhibits RANK Ligand (RANKL). In GCTB, the neoplastic mononuclear stromal cells express high levels of RANKL, which recruits and activates the reactive multinucleated giant cells (osteoclast-like cells) that cause extensive bone osteolysis.

Question 918

Topic: Biology, Genetics & Bone Healing

Romosozumab is currently utilized in the treatment of severe osteoporosis. What is the specific cellular mechanism of action of this medication?

. Inhibits RANKL to prevent osteoclastogenesis
. Binds to sclerostin to disinhibit Wnt/beta-catenin signaling
. Directly stimulates osteoblast parathyroid hormone receptors
. Binds to cathepsin K to prevent bone resorption
. Acts as a selective estrogen receptor modulator (SERM)

Correct Answer & Explanation

. Binds to sclerostin to disinhibit Wnt/beta-catenin signaling

Explanation

Romosozumab is a humanized monoclonal antibody that binds to and inhibits sclerostin. By inhibiting sclerostin, it disinhibits the Wnt/beta-catenin signaling pathway, leading to increased bone formation and decreased bone resorption (a dual-acting anabolic agent).

Question 919

Topic: Biology, Genetics & Bone Healing

A 28-year-old female presents with a destructive, expansile lytic lesion in the distal femur epimetaphysis. Biopsy confirms a Giant Cell Tumor of Bone. She is started on Denosumab preoperatively. Which of the following describes the primary histological effect of Denosumab on this tumor?

. Elimination of the neoplastic mononuclear stromal cells
. Elimination of the reactive multinucleated giant cells
. Induction of massive ischemic necrosis of the tumor bed
. Inhibition of vascular endothelial growth factor (VEGF)
. Promotion of chondroid differentiation in the stromal cells

Correct Answer & Explanation

. Elimination of the reactive multinucleated giant cells

Explanation

Denosumab is a RANKL inhibitor. In Giant Cell Tumor of Bone, the neoplastic mononuclear stromal cells express RANKL, which recruits reactive multinucleated osteoclast-like giant cells. Denosumab inhibits this recruitment, leading to the rapid depletion of the giant cells and subsequent woven bone formation, but the neoplastic stromal cells often remain viable.

Question 920

Topic: Biology, Genetics & Bone Healing

During the incorporation of a cortical structural allograft, the process of 'creeping substitution' occurs. Which of the following correctly describes the sequence of cellular events in this process?

. Direct lamellar bone formation by circulating mesenchymal stem cells
. Osteoclast resorption followed immediately by osteoblast new bone deposition
. Chondrocyte hypertrophy followed by endochondral ossification
. Osteoblast woven bone formation followed by osteoclast resorption
. Fibrous tissue interposition followed by intramembranous ossification

Correct Answer & Explanation

. Osteoclast resorption followed immediately by osteoblast new bone deposition

Explanation

Creeping substitution is the process by which a bone graft is slowly resorbed and simultaneously replaced with new living bone. For dense cortical grafts, this occurs via a 'cutting cone' mechanism, where osteoclasts lead the way by resorbing the Haversian canals, followed closely by osteoblasts laying down new osteoid.

Test Yourself

Switch to an interactive, timed exam simulation to truly master this topic.

On this Page